JK

Jaspreet Kaur

Active Director Director DIN 07690901
DIN 07690901 First appointment Jul 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Jaspreet Kaur

Data last updated:

Jaspreet Kaur is a Director at Prosum Medical Private Limited (since 2022). The company operates in Pharma. Prosum Medical Private Limited reported revenue of ₹72.3 Lakh (FY 2025).

DIN 07690901
Primary Designation Director
Industry Pharma
First Appointment 20 Jul 2022
Oldest Company Age 9 yrs
Largest company Prosum Medical Private Limited · ₹72.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prosum Medical Private Limited U52300PB2017PTC046055
Director20 Jul 20222017₹72.3 Lakh (FY 2025)Active

Board colleagues of Jaspreet Kaur

NameDINCompanyDesignation
Ranjit Kaur Sahni07691310Prosum Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Prosum Medical Private Limited
Premium access

Shareholding and investment profile for Jaspreet Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaspreet Kaur

Jaspreet Kaur currently holds 1 directorship: Prosum Medical Private Limited (Director, since 20 Jul 2022, revenue ₹72.3 Lakh (FY 2025)).

Jaspreet Kaur was first appointed on 20 Jul 2022 as Director at Prosum Medical Private Limited.

The current boards of Jaspreet Kaur's companies include Ranjit Kaur Sahni (Prosum Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available